NHL highlights at ASH 2022: updates in MCL, the role of transplantation, and novel bispecific antibodies
VJHemOnc Podcast
00:00
Long-term follow-up and sequencing of CAR-T treatments in patients with aggressive B-cell lymphomas
Discussion on the long-term follow-up and potential sequencing of CAR-T treatments in aggressive B-cell lymphomas, including the use of off-the-shelf bispecific agents and their activity in patients who have received CAR-T cell products. Speculation on the role of bispecifics in combination with frontline chemotherapy regimens and their use in multiple lines of therapy.
Transcript
Play full episode
